Youtube Pro Stock Picks

Click here to search for stock quotes, financial statistics and more.

or

Life Sciences

Theratechnologies
Analysts Life Sciences thtx
Theratechnologies shareholders should take the deal, Research Capital says

Research Capital analyst Andre Uddin is recommending Theratechnologies (Theratechnologies Stock Quote, Chart, News, Analysts, Financials NASDAQ:THTX) shareholders tender their shares to the proposed US$4.20 per share acquisition offer from CB Biotechnology, an affiliate of Future Pak. In a July 3 report, Uddin said the total offer, comprised of US$3.01 in cash and up to US$1.19 […]

MDP stock
Analysts Life Sciences mdp
Medexus Pharmaceuticals is a buy, Research Capital says

Research Capital analyst Andre Uddin maintained a “Buy” rating and C$5.55 price target on Medexus Pharmaceuticals (Medexus Pharmaceuticals Stock Quote, Chart, News, Analysts, Financials TSXV:MDP) in a June 26 note, following fourth-quarter fiscal 2025 results that showed stabilizing revenue and progress in reducing debt. Medexus reported Q4 revenue of $24.8-million, nearly matching Uddin’s estimate of […]

AIDX
Share Tweet linked In Share

Get Stock Picks from the Pros.
In your Inbox.

AEterna Zentaris today announced its lead offering, Perifosine, failed to meet its primary endpoint. Byron Capital analyst Douglas Loe downgraded the stock and reduced his twelve-month target price.

Bad news for shareholders of AEterna Zentaris (TSX:AEZ) today as the company announced its lead offe...

Theralase CEO White:

Anyone who has lost a family member to cancer knows that scientific progress in beating the disease ...

Oncolytics Biotech CEO Brad Thompson. Byron Capital analyst Douglas Loe has a $9 target on the company's stock.

Last month, Calgary’s Oncolytics Biotech (TSX:ONC) completed a bought deal financing, raising ...

Byron Capital healthcare analyst Douglas Loe believes that allergy treatment Oralair could become a leading product in Paladin Labs' already diverse offering.

Paladin Labs (TSX:PLB) yesterday announced it has received approval from Health Canada for it grass ...

Verisante (TSXV:VRS) today announced that the results of a clinical study on its Aura device will be...

Some surprising news from Cardiome (TSX:COM) today as the company announced that Merck will disconti...

CRH Medical

In biotech, playing the waiting game is just part of the gig. Between clinical trials, patent applic...

Thierer:

Ask the average Canadian to name our biggest success stories in the technology space and you will, d...

Yesterday, TSO3 (TSX:TOS) announced that the US Regulatory Agency requested more information about i...

IMRIS CEO David Graves. On Friday, Byron Capital Healthcare Analyst Douglas Loe reiterated his BUY rating and $8 target on the stock.

On Thursday, IMRIS (TSX:IM) reported its Q4 and fiscal 2011 results. Across the board, the numbers w...

Titan Medical President Reiza Rayman. The company says the current market for robotic surgery is about $1 billion now, but will grow to $5 billion by 2015.

Investment themes come and go. Whether it’s internet advertising sending your daily hometown n...

Dr. Yves Fradet, President of Diagnocure. On Wednesday, Byron Capital analyst Douglas Loe upgraded the company to Buy from Speculative Buy because he says Diagnocure is no longer as subject to clinical or regulatory risk.

This past Wednesday DiagnoCure (TSX:CUR), along with its US-based partner Gen-Probe, received FDA ap...

Dacryocytes, or teardrop-shaped cells, are found in myelofibrosis and myelophthisic states of bone marrow. Mississauga's YM Bioscience's Myelofibrosis treatment, CYT387, has performed well in Phase Two trials. Byron Capital Healthcare analyst Douglas Loe thinks this may soon attract a larger

Last Thursday, YM Biosciences (TSX:YM) reported its Q2, 2012 results. The company lost $6.55-million...

Monique Champagne, Bioniche Life Sciences VP, Clinical Research and Graeme McRae, the company's CEO accept an Accolades 2011 Award of Excellence for High Technology and Innovation from The West Island of Montreal Chamber of Commerce on May 26, 2011.

A cursory glance at a three-year chart of Belleville’s Bioniche Life Sciences (TSX:BNC) illust...

Market research firm Global Industry Analysts says the global market for 3D medical imaging will reach (US) $5.9 Billion by 2017.

2008 was supposed to be Medipattern’s (TSXV:MKI) big year. The Toronto based company, which de...

Protech

Shares of CardioComm (TSXV:EKG) were on fire today after the company announced it had cleared an imp...

If you want telecom you go to Ottawa. If you want oil and gas technology, go to Alberta. When it com...

Neptune Technologies

Neptune Technologies (TSXV:NTB) yesterday reported its Q3, 2012 results. The numbers appeared to be ...

AIDX
Share Tweet linked In Share

Get Stock Picks from the Pros. In your Inbox.

TRENDING

All Trending →
PLUG stock

How will Plug Power deal with the “Big Beautiful Bill”?

 July 11, 2025
WELL stock

WELL Health Technologies has an “increasingly attractive growth profile”, Raymond James says

 July 10, 2025
VitalHub

VitalHub wins price target raise at Paradigm Capital

 July 9, 2025
FLT stock

Ventum raises price target on Volatus Aerospace to $0.50

 July 9, 2025
AC stock

Air Canada stock is a buy, Citi says

 June 30, 2025